BC-CfE

HIV/AIDS Treatment as Prevention strategy working in B.C. Montaner calls for national implementation

A new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE) shows highly active antiretroviral therapy (HAART) reduces new HIV diagnoses, deaths and HIV prevalence, suggesting that the made-in-Canada Treatment as Prevention strategy should be implemented across the country.

Nov 27, 2012

Adherence to HIV treatment significantly increases survival: UBC study

HIV-positive individuals who strictly adhere to highly active antiretroviral therapy (HAART) have a significantly lower probability of premature morbidity and mortality as compared to those with suboptimal compliance to HAART, according to a new study from the BC Centre for Excellence in HIV/AIDS (BC-CfE).

Nov 20, 2012

UBC researcher wins 2012 Trudeau Foundation scholarship

Daniel Werb, senior research assistant at the Addiction and Urban Health Research Initiative (UHRI) at the BC Centre for Excellence in HIV/AIDS (BC-CfE), has been awarded the 2012 Pierre Elliott Trudeau Foundation Doctoral Scholarship for his PhD research project investigating initiation and cessation of injection drug use among street youth in Vancouver.

May 15, 2012

Allegations against UBC researchers’ study on Insite “without merit:” independent reviewer

An independent reviewer has dismissed concerns over a study that shows a 35-per-cent decrease in overdose deaths after the opening of Insite, North America’s only supervised injection facility.

Oct 18, 2011